Kurma Partners β Full Portfolio
64 tracked investments Β· listed companies and verified rows first
Brink Therapeutics is a TechBio company developing programmable integrases, a nuclease-free platform for precise, large-payload genomic insertion of therapeutic genes for cell and gene therapy.
AI & Machine LearningBiotechDeep TechParis, FR
Jonathan Naccache(Co-founder (Directeur de la publication))inHarryinAndrew
Alveus Pharmaceuticals offers pharmaceutical development and manufacturing services, including analytical development, product formulation, quality and regulatory support, and process validation, aligned with the relevant phase of drug development.
BiotechHealthtech
PanTera develops actinium-225, a therapeutic radioisotope used in precision cancer treatment through radiotheranostics, serving oncology patients and pharmaceutical companies globally.
BiotechDeep TechHealthtechMedical DevicesMol, BE
Sven van den berghe(CEO)Christophe Malice(CBO)Samy Bertrand(CTO)Yves Sterckx(Director of Finance & Administration)Philippe Vanwolleghem(Director Quality, Regulatory Affairs & HSE)
SmartCatch is a CNRS spin-off developing micro/nanotechnology-based medical solutions, founded by researchers from the LAAS-CNRS laboratory together with urology surgeons from cancer institutes in Toulouse.
Deep TechHealthtechMedical DevicesPortola Valley, US
RICHARD DEATLEY(Director)ROBERT TERRY(Director)TJ DURNAN(Director)MARK DAHM(Executive Officer, Director)
San Francisco, US
Richard Harroch(Executive Officer, Director)Michael Barber(Director)Philip Dur(Executive Officer, Director)Ashmi Shah(Executive Officer)Dean Stephens(Executive Officer, Director)Shahyan Currimbhoy(Executive Officer)
Vivet Therapeutics is a company focused on gene and cell therapy development, presenting research at major scientific conferences.
BiotechParis, FR
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.